Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

2021132 citationsJournal Articlegold Open Access

Authors

Combination of LEN, PD-1 and TACE showed a high rate of tumor response and convert resection in uHCC patients, with manageable toxicity.

Good health and well-being

Published in: Journal of Hepatocellular Carcinoma

Volume Volume 8, pp. 1233-1240

Field-Weighted Citation Impact: 12.30